snIP/ITs Insights on Canadian Technology and Intellectual Property Law

Monthly Archives: July 2012

Recent Pair of Rampiril Decisions Clarifies Limits on s. 8 Damages in Patent Law

By Fiona Legere on Posted in Intellectual Property, Patents

When a generic drug claims damages against a brand name drug, what limits should be put on calculating compensation? Section 8 of the Patented Medicines (Notice of Compliance) Regulations was designed to answer just that question, but it left some questions unanswered. A pair of twin judgments by Justice Snider, Teva Canada Ltd. v. Sanofi-Aventis… → Read More

Responding to Canadian Patent Office Objections: Dosing Regimens

By Lisa Melanson on Posted in Intellectual Property, Patents

This is part of a series of posts reviewing common Canadian Patent Office objections to patent applications and claimed inventions and providing some insight into how these objections may be addressed. The Objection In a typical objection, the patent examiner asserts that the claimed medical treatment with dosing elements is unpatentable subject matter falling outside… → Read More

1930 Applications for New Generic Top Level Domains Published

By Keith Chung on Posted in E-Commerce, Intellectual Property

An eagerly awaited list of applications for new generic top-level domains (gTLDs) was recently revealed, disclosing 1930 applications for a wide variety of potential new gTLDs. These ranged from multiple applications for expected gTLDs such as .app and .shop, to more unexpected gTLDs such as .sucks and .webcam. The number of applications is particularly surprising given… → Read More